Chinese biotech firm challenges U.S. military-linked business list
Original framing: “Biotech firm WuXi sues US over allegations it supports China’s military” — South China Morning Post
This case echoes historical patterns of economic nationalism and the use of trade policy as a tool of geopolitical leverage. Similar dynamics were seen during the Cold War with technology embargoes and more recently with the U.S.-China trade war. These precedents show how economic decisions are often driven by strategic competition rather than purely commercial interests.
The WuXi AppTec case is emblematic of a deeper systemic conflict between U.S. and Chinese strategic interests in the biotech sector.
It reveals how economic policy is increasingly weaponized in geopolitical competition, often at the expense of scientific collaboration and innovation. Historical precedents show that such tensions are not new, but the current context of rapid technological change and global interdependence demands more nuanced and inclusive approaches. By integrating indigenous knowledge, promoting multilateral science diplomacy, and enhancing transparency, we can begin to address the structural issues that underpin these conflicts. The voices of marginalized communities and the principles of ethical science must be central to any future governance frameworks.